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Background: The prevalence of MRSA (Methicillin-resistant Staphylococcus aureus) colonized
wounds in home care residents is expected to grow continuously as a result of the substantial
proportionof older people requiring institutionalizedcaredue to chronicdisease anddeclining
functional status, which contribute to more frequent skin breakdown and wound formation.
Tea tree oil has been claimed to have anti-bacterial, analgesic and anti-inflammatory effects
that have been suggested in many in-vitro studies to have good efficacy against MRSA. The
aims of this study were to evaluate the effectiveness of 10% topical tea tree preparation to
eradicate MRSA and to ascertain its influence onwound healing for MRSA-colonized wounds.
Methods: It was a randomized controlled trial, single-blind study. Those with stage II or above
MRSA-colonized wounds and who had given their informed consent formed the sample. The
determinedsamplesizewasbasedontheeffect sizeofourpreviouspilotstudy,whichwas0.46.
Five outcome measurements were taken for the MRSA bacterial count and wound healing
condition at baseline and at 1-week intervals during the 4-week dressing intervention period.
Results: Thirty-two participants were recruited from two non-government nursing homes,
16 in the control group and 16 in the tea tree oil group. The control group residents received
routine saline gauze dressing, while the tea tree oil group residents received the 10%
topical tea tree preparation dressing. In the tea tree oil group, all chronic wounds that had
previously been delayed in healing were healed within 28 days without adverse reaction.
MRSA was also completely eradicated in 14 (87.5%) out of 16 wounds in the group receiving
the 10% topical tea tree preparation.
Conclusion: The 10% topical tea tree preparation was effective in reducing the quantity of
colonized MRSA in and promoting healing of chronic wounds among elderly.
Copyright ª 2014, Chinese Nursing Association. Production and hosting by Elsevier
(Singapore) Pte Ltd. All rights reserved.om (T.K.S. Wong).
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formulated 10% topical tea tree oil preparation.Older people who are institutionalized are particularly sus-
ceptible to MRSA infection due to their chronic illness, mul-
tiple exposures to antibiotics, and the presence of invasive in-
dwelling devices leading to debilitation, immobility and
compromised immune response [1,2]. Wound chronicity is a
commonly found health problem among these residents. It
constitutes a well known risk for MRSA colonization [3].
Two critical factors have been considered that make MRSA
colonized wounds particularly prevalent in nursing home
residents. The first factor is related to the wound. MRSA has
the ability to disrupt the normal wound healing process,
leading to prolongedwound healing. The second factor relates
to persistent wound carriage with MRSA, which serves as a
reservoir for MRSA infection. The relationship between colo-
nization and the development of infection is complex. Wer-
theim and colleagues estimated the risk of infection in
colonizers is 2e12 times higher than in those who are not
colonized with Staphylococcus aureus [4]. In the context of
nursing homes, Capitano reported that MRSA colonized resi-
dents were up to 6 times more likely to develop infection than
non-colonized patients [5]. The risk of infection associated
with MRSA colonization in chronic wounds might be even
greater. Over time, there have been frequent reports of MRSA
wounds being a source for other MRSA nosocomial infections,
leading to the occurrence of bacteremia, endocarditis, and
osteomyelitis [6e8]. For example, Manzur et al. demonstrated
a strong and independent association between MRSA blood-
stream infections and admission from nursing homes [9].
Therefore, to control the spread of MRSA from colonized res-
idents in nursing homes, attempts must be made to eradicate
MRSA wound carriage.
Over the past three decades, tea tree oil has been claimed
to have anti-bacterial, analgesic and anti-inflammatory ef-
fects against MRSA [10e12]. Small human trials utilizing tea
tree oil in wounds suggested that it might be effective as a
topical therapy for chronic wounds such as diabetic ulcers,
osteomyelitis, pressure ulcers and other wounds [13e15]. The
scientific evidence to support this claim, however, has yet to
be further substantiated. To this end, the research team
developed a topical tea tree oil dressing model, put it into
action and evaluated its effectiveness for MRSA eradication
and wound healing enhancement.Component Study tea tree oil (%)
Terpinen-4-ol 30
g-Terpinene 10e28
a-Terpinene 5e13
1,8-Cineole 153
Terpinolene 1.5e5
r-Cymene 0.5e12
a-Pinene 1e6
a-Terpineol 1.5e8
Aromadendrene Traces e 7
d-Cadinene Traces e 8
Limonene 0.5e4
Sabinene Traces e 3.5
Globulol Traces e 3
Viridiflorol Traces e 1.5
Paraffin oil 902. Design and method
This was a randomized controlled trial, single-blind study.
The recruited participants were randomly assigned to either
the control or Tea Tree Oil (TTO) group with the Principal
Investigator being blind to the allocation. The study included
the followings:
(1) Formulation of a 10% topical tea tree oil preparation as a
topical therapy for older people with MRSA colonized
wounds
(2) Evaluation of the possible adverse reactions to the
formulated 10% topical tea tree oil preparation(3) Evaluation of the efficacy of 10% tea tree oil preparation
for eradication of MRSA and improvement in the heal-
ing of MRSA colonized wounds.
2.1. Topical tea tree oil formulation
The product used in this study was an oil-miscible 10% v/v tea
tree oil solution packaged in 30ml light-resistant glass bottles.
The pure 100% tea tree oil was ordered from the NOW Foods
Company (Bloomingdale, U.S.A.), certified by Quality Assur-
ance International with the international standard ISO4730
[16]. A medical grade paraffin oil acting as the solvent was
then used to dilute the pure 100% tea tree oil in the laboratory
of the Hong Kong Polytechnic University. The topical tea tree
oil preparation was prepared at 10% tea tree oil to 90% paraffin
oil and its composition is listed below (Table 1).
As the chemical compositions of tea tree oil are sensitive to
light, the formulated topical tea tree preparation was then put
into a light-resistant glass bottle immediately. All equipment
used in the preparation of the studied product had undergone
the complete procedure of sterilization using an autoclave
machine (Autoclave Tauttnauer Model 2540EK, U.S.A.).
2.2. Sampling
The study was conducted in two non-governmental organi-
zation (NGO) nursing homes. They are supported and run by
two major charity groups in Hong Kong, the Yuen Yuen In-
stitutes and the Evangelical Lutheran Church of Hong Kong.
The one under the Yuen Yuen Institute contains around 150
beds for permanent residents and a few places in the day care
centre. The other one, run by the Evangelical Lutheran Church
of Hong Kong, contains approximately130 beds. The research
team applied to these homes following the approval by the
Human Subjects Ethics Sub-committee of The Hong Kong
Polytechnic University. With their approval, recruitment of
residents commenced using the following criteria.
2.2.1. Inclusion criteria
The inclusion criteria were having open chronic wounds with
positivity in MRSA wound culture. The chronic wound in this
i n t e r n a t i o n a l j o u rn a l o f n u r s i n g s c i e n c e s 1 ( 2 0 1 4 ) 7e1 4 9studywasdefinedasabreakof skinof longduration (>6weeks)
without progress to healing through normal repair process
[17]. If the resident had multiple wounds, the largest wound
was nominated as the primary wound for inclusion in this
study.
2.2.2. Exclusion criteria
The exclusion criteria were suffering from peripheral vascular
disease, using systemic or topical antimicrobial treatment,
having clinical signs of infection, and more than 105 MRSA
bacteria per gm of wound tissue being detected from theMRSA
wound surface culture.Woundswith undermining or tunneling
were also excluded in the present study. Participants who have
known sensitivity and allergy to tea tree oil or its major com-
ponents (i.e. terpinen-4-ol, 1,8-cineole, a-terpineol, terpinolene
or a-and g-terpinene) were excluded from the study.
The estimated sample size in this study was based on the
effect size of the pilot study conducted by the research team,
which was 0.46. Thirty-two participants (i.e. 16 in each group)
would reach 80% power at a significance level of 0.05 to detect
a clinically significant difference between the control and TTO
groups.
The residents of the two nursing homes with stage II or
above MRSA-colonized wounds formed the sample. For resi-
dents who were cognitively capable (n ¼ 10), the Principal
Investigator explained the details of the study to them before
they signed the consent form, while relatives signed on behalf
of those who were not (n ¼ 26). All participants were assured
that there would be no penalty if they refused to participate or
withdrew from the study at any time throughout the study
period.
2.3. Procedures
The participants were selected based on two indicators.
Firstly, the studied wound should be at the level of stage II or
above in a wound staging assessment using the pressure ulcer
categorization stipulated by the National Pressure Ulcer
Advisory Panel [18]. Secondly, the studied wound should be
colonized with MRSA as confirmed by the positive results of
MRSAwound cultures. Baseline data were collected at the first
visit, and included wound assessment and measurement,
relevant medical history, and a baseline wound culture to
confirm the quantitative numbers of MRSA isolates (bio-
burden level) present on the wound surfaces. A research as-
sistant who was a registered nurse trained for data collection
assessed the wound and took the wound culture and another
registered nurse who was well trained in wound dressing
methods changed the dressing of the participant’s wound
daily. Both trainngs were conducted by the Principal
Investigators.
2.3.1. Wound dressing
The participants were randomized into either the TTO group
or the control group. In the TTO group, the wound was
cleansed gently with 0.9% normal saline to remove any debris
and loose necrotic tissue, and 10% topical tea tree preparation
was then soaped with a dressing applicator and applied onto
the wound surface. A non-adhesive pad was placed to cover
the wound. The participant’s wound was cleansed the sameway as that for the TTO group. Their wounds did not have any
tea tree preparation before they were covered by a non-
adhesive pad. In other words, the dressing procedure for the
control group was the same as what the nurses did everyday
in the nursing homes. Nevertheless, the participants in this
group were told that if the tea tree dressing model was found
effective, they would be given the opportunity to receive this
treatment after the present study.
2.3.2. Adverse reactions
Daily nurse rounds were conducted throughout the study
period to assess the participants’ level of consciousness, blood
pressure, temperature, heart rate, respiratory rate and oxygen
saturation. Inspection of skin on the whole body and sur-
rounding the wound were performed at the same time in
order to detect whether any form of allergy or adverse reac-
tion had occurred. Participants’ pain was also examined by
direct verbal communication. For non-communicative par-
ticipants, facial expression and body gesturewere scrutinized.
Adverse reactions were categorized based on the level of
severity as either adverse reactions or severe adverse re-
actions. Adverse reaction refers to any untoward medical
occurrence in a clinical investigation, which does not neces-
sarily have a causal relationship with this treatment. It can
therefore be any unfavorable and unintended sign (including
an abnormal finding), symptom, or disease temporarily asso-
ciatedwith the use of an investigation product, whether or not
related to the product under investigation [19]. Severe adverse
reaction refers to any untoward medical occurrence that at
any dose results in death or threat to life, requires inpatient
hospitalization, results in persistent or significant disability/
incapacity [19]. For the purpose of this study, the Principal
Investigator told the participants that the ir participation
would be terminated if they had an allergic reaction to the
treatment.
2.3.3. Wound measurement
Wound measurements were obtained by first tracing the
wound and then calculating the wound healing condition
using the Pressure Ulcer Scale for Healing (PUSH) tool 3.0,
where surface area (wound size), exudate, and type of wound
tissue are assigned different sub-scores ranging from 0 to 4
[20]. A comparison of total scores by adding together these
sub-scores measured over time provides an indication of the
improvement or deterioration in wound healing. A score of
0 out of 16 is an indicator of a completely healed wound. In
total, five measurements were performed on all participants:
before the implementation of wound dressing, the 1st week
after the implementation of wound dressing, the 2nd week
after the implementation of wound dressing, the 3rd week
after the implementation of wound dressing, and the 4th
week after the implementation of wound dressing.
2.3.4. Wound culture
Wound culture was performed using the wound swabbing
method to obtain the MRSA isolates present on the surface of
the wounds with a sterile swab stick. Before the swab stick
was used, old dressings were removed and the wound be
cleansed with 0.9% normal saline to remove dressing debris,
exudates and loose devitalized tissue. The swab stick was
Table 2 e Demographic and wound characteristics.
Group Demographics Wound characteristics
Mean age* Sex Mean wound
size** cm2
Pressure
ulcer
Leg ulcer Toe ulcer Allergic
reactionMale Female
Control 79  6.9 4 12 3.98 11 5 0 0
Tea tree group 81  7.6 3 13 3.41 12 2 2 0
Note: Levene’s Test for Equality of Variances: *F ¼ 0.005, p ¼ 0.946; **F ¼ 0.519, p ¼ 0.477.
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wounds were swabbed using pre-moistened (with 0.9%
normal saline) swab sticks. The freshly taken wound swabs
were then transported to the laboratory immediately for
microbiological analysis to identify the quantity of MRSA
isolates colonized on the wounds. Each wound swab spec-
imen was placed in a 10 ml sterile normal saline glass bottle
for storage. The wound specimens were then sent to the lab-
oratory immediately for culture and susceptibility testing. In
the laboratory, 1 ml of the mixed wound specimen was aspi-
rated from the normal saline glass bottle. The solution was
then dipped vertically at the centre of the MRSASelectTM (Bio-
Rad, CA, USA) agar plate by a calibrated loop. Vortex and
cross-streaking were performed to ensure that all MRSA iso-
lates on the wound swab were evenly distributed and
extended towards the edge of the agar plates. The agar plates
were then incubated in an inverted position aerobically at
35 C for 18e24 h. Suspected MRSA colonies were examined
and subsequently confirmed using Staphaurex (Remel, KS,
USA) for coagulase production and cefoxitin antibiotic disc
(Becton Dickinson, NJ, USA) for methicillin resistance. The
MRSA isolates appeared as small pink colonies with clear
zones on the agar plates. The quantification of MRSA isolates
were read and measured by counting the number of colony-
forming units on each plate with the Automated Colony
Counter (Acolyte, Synbiosis, USA). A comparison of quantita-
tive numbers of MRSA isolates (bio-burden level) throughout
the study provides an indication of whether MRSA was erad-
icated or not. Like wound assessment, five measurements
were taken for MRSA wound cultures. They were taken at
baseline (i.e. before implementation of wound dressing), and
at one-week intervals for four weeks (i.e. the 1st, 2nd, 3rd and
4th weeks after implementation of wound dressing) during
the wound dressing intervention period.
2.3.5. Statistical analysis
The data collected were analyzed using the Statistical Package
for the Social Sciences (SPSS) for Windows version 17.
For wound characteristics and demographic information,Table 3eMeans and standard deviations comparing the contro
at the time points indicated.
Quantity of MRSA in CFU/ml n Baseline 1st w
M SD M
Control group 16 6437 1209 8125
Tea tree group 16 7093 1356 4531
Total 32 6765 1307 6328descriptive statistics including frequency, distribution and
percentages were used. On the other hand, for outcomes
measures in this study such as quantity of MRSA isolates
present on the wounds and PUSH scores for wound healing,
inferential statistics was deployed. The difference in quantity
of MRSA isolates and PUSH scores between the groups was
analyzed by one-way ANOVA, whereas the difference within
the groups was analyzed by ANOVA with repeated measures.
The level of significance was set as 0.05, with the power of 0.8.
The incidence of adverse reactions was the number of resi-
dents identified with adverse reactions such as fever, rash,
pruritus, irritation, pain, inflammation and edema during the
intervention period. Descriptive data yielded on adverse re-
actions, if any, were subject to content analysis. All analyses
were carried out following the intention-to-treat principle
with participants receiving not less than five days of dressing
interventions counted.3. Results
3.1. Demographic and wound characteristics
A total of 32 participants with the same number of MRSA
colonized wounds were recruited in the study. The partici-
pants in the control group consisted of sixteen participants,
four (25%)males and twelve (75%) females. The participants in
the TTO group also consisted of sixteen participants, three
(18.8%) males and thirteen (91.2%) females. The mean partic-
ipant age in the control group was 79.4 (6.9) and that in the
tea tree oil group was 81 (7.6) years. Themean wound size in
the control group was 3.98 square centimeters, while that of
the TTO group was 3.52 square centimeters. Eighteen (56.3%)
pressure ulcers, twelve (37.5%) leg ulcers, and two toe ulcers
(6.2%) were identified. There were eleven (68.8%) pressure ul-
cers and five (31.2%) leg ulcers in the control group, and twelve
(75%) pressure ulcers, two (12.5%) leg ulcers and two (12.5%)
toe ulcers were found in participants recruited to the TTO
group (Table 2). To ensure the homogeneity of the participantsl and tea tree groups in terms of quantity ofMRSA in CFU/ml
eek 2nd week 3rd week 4th week
SD M SD M SD M SD
1821 8937 2174 9875 2610 10312 3054
1783 2375 1284 468 590 93 201
2545 5656 3768 5171 5128 5203 5610
Table 4eOne-wayANOVA comparing the control and tea
tree oil groups in terms of quantity of MRSA.
Quantity of MRSA df F p
Baseline
Between groups 1 2.08 0.159
Within groups 30
Total 31
1st week
Between groups 1 31.8 <0.001
Within groups 30
Total 31
2nd week
Between groups 1 108.0 <0.001
Within groups 30
Total 31
3rd week
Between groups 1 197.6 <0.001
Within groups 30
Total 31
4th week
Between groups 1 178.3 <0.001
Within groups 30
Total 31
Table 5 e Comparison of the PUSH scores of the control
and tea tree oil groups at the time points indicated.
PUSH
score
Baseline 1st
week
2nd
week
3rd
week
4th
week
Control
group
8.1 7.6 6.9 5.5 4.6
Tea tree
group
7.9 5.5 5.4 1.0 0
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ances of age and wound size was performed. Both did not
show any statistical significance (p > 0.05) (Table 2).
3.2. Allergy and adverse reaction
There were no reports of adverse effects or allergic reactions,
such as fever, rash, pruritus, irritation, pain, inflammation or
edema, or of intolerance to the use of 10% topical TTO prep-
aration (Table 2) .
3.3. Outcomes of wound culture
Mean data of the wound surface cultures in the control and
TTO groups are shown in Table 3, which reports the quantity
of MRSA in terms of colony-forming units per gram of wound
tissue (CFU/ml). A decrease of the mean viable count of MRSA
was seen in the TTO group at each time interval of the five
measurements. Compared with the baseline (7093 CFU/ml),
viable MRSA in wounds at the 1st (4531 CFU/ml), 2nd
(2375 CFU/ml), 3rd (468 CFU/ml) and 4th weeks (93 CFU/ml)
was reduced by 36%, 66%, 93% and 98%, respectively. In
contrast, an increase in the mean viable count of MRSA was
noted in the control group. Compared with the baseline
(6437 CFU/ml), viable MRSA at the 1st (8125 CFU/ml), second
(8937 CFU/ml), third (9875 CFU/ml) and fourth (10312 CFU/ml)
measurements was increased by 26%, 39%, 53% and 60%,
respectively. One-way ANOVAwas used to identify significant
differences in MRSA quantity between the control and TTO
groups. The results reveal a statistically significant difference
between groups at the 1st, F (1, 30) ¼ 31.8, p  0.001; 2nd,
F (1, 30)¼ 108, p 0.001; 3rd, F (1, 30)¼ 197.6, p 0.001; and 4th
weeks, F (1, 30) ¼ 178.3, p  0.001 (Table 4) in terms of eradi-
cation of MRSA. A repeated measures ANOVA with a
Greenhouse-Geisser correction in the tea tree oil group
determined that mean MRSA quantity differed statistically
significant between the 1st, 2nd, 3rd and 4th week of dressing
interventions (F(2.64, 39.62) ¼ 140.64, P ¼ 0.000). Post hoc tests
using the Bonferroni correction revealed that topical tea tree
oil dressing elicited a reduction of MRSA isolates on the
studied wounds from the 1st week to the 4th week of dressing
interventions (4531  1784 CFU/ml vs 2375  1285 CFU/ml vs
469  591 CFU/ml vs 94  202 CFU/ml respectively), which
were statistically significant (p¼ 0.000 vs p¼ 0.000 vs p¼ 0.000
vs p ¼ 0.000 respectively). The effect size was 0.965.
3.4. Outcomes of wound measurement
Mean data of the PUSH scores in the control and TTO groups is
shown in Table 5, with increasing PUSH scores indicating
deterioration in wound healing and vice versa. The baseline
PUSH score of the TTO group was 7.9. The first, second, third
and fourthmeasurements were 5.5, 5.4, 1.0 and 0 respectively.
A decrease in PUSH scores was observed in the TTO group.
Compared with the baseline, the percentage decreases at the
first, second, third and fourth measurements were 30.4%,
31.6%, 87% and 100% respectively (Figs. 1 and 2). At the fourth
measurement, all studied wounds in the TTO group showed
complete healing.With regard to the control group, a decrease
in the PUSH score was noticed over time. Compared with thebaseline (8.1), the decrease at the first (7.6), second (6.9), third
(5.5) and fourth (4.6) measurements was 6.2%, 8.6%, 17.3% and
43.2% respectively. One-way ANOVA was used to identify
significant differences in PUSH scores between the control
and TTO groups. The results reveal a statistically significant
difference between groups at the 1st, F (1, 30) ¼ 9.369,
p ¼ 0.005; 2nd, F (1, 30) ¼ 40.8, p ¼ 0.000; 3rd, F (1, 30) ¼ 80.67,
p ¼ 0.000; and 4th weeks, F (1, 30) ¼ 71.60, p ¼ 0.000 (Table 6) of
dressing intervention period. A repeated measures ANOVA
with a Greenhouse-Geisser correction in the tea tree oil group
determined that mean PUSH scores differed statistically sig-
nificant between the 1st, 2nd, 3rd and 4th week of dressing
interventions (F(1.97, 29.56) ¼ 124.20, P ¼ 0.000). Post hoc tests
using the Bonferroni correction revealed that topical tea tree
oil dressing secured an improvement in the healing of MRSA
colonizedwounds from the 1st week to the 4th week of topical
tea tree preparation dressing interventions (5.5  2.4 vs
2.5  2.5 vs 0.94  1.44 vs 0  0 respectively), which were
statistically significant (p ¼ 0.000 vs p ¼ 0.000 vs p ¼ 0.000 vs
p ¼ 0.000 respectively). The effect size was 0.89.4. Discussion
In the present study, 10% topical tea tree preparationwas used
to manage chronic wounds colonized with MRSA in nursing
Fig. 1 e The pictures of the wound of one tea tree oil group participant who had a foot ulcer of 3 months duration. The
pictures were taken on enrollment (A), 2 weeks after tea tree oil dressing intervention (B) and 4 weeks after treatment
dressing intervention (C).
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wounds in the tea tree oil groupwere completely eradicated of
MRSA by the end of the 4-week study period. Regarding
wound healing, 16 MRSA colonized wounds in the tea tree oil
group were closed skin by 28 days. These suggest that 10% tea
tree oil is feasible for topical wound treatment, for both MRSA
eradication and wound healing improvement. The tea tress
preparation is evidently an acceptable and appropriate
formulation that can be used in older people and nursing
home settings. Although the product we formulated is not
commercially available now, pure 100% tea tree oil is available
at low cost over the counter and through pharmaceutical
suppliers. Thus tea tree oil’s market value for chronic wound
management is finite.
Throughout the world, the growing problem of antimicro-
bial resistance and the global emergence of multi-drug-
resistant organisms in acute healthcare settings and in the
community, including nursing homes, have caused concern to
our healthcare policy makers. There is no doubt that MRSA is
one of the most important antimicrobial-resistant bacteria in
Hong Kong. The annual report of the Hong Kong Hospital
Authority stated that the number of patients with MRSA for
2009 was estimated to be about 7000 [21]. Even if only 10% of
the MRSA infections were prevented, the number of lives
saved and unnecessary operations avoided would exceed the
benefits associated with preventing all other sentinel events
combined. The Chief Executive further explained that it wasFig. 2 e The pictures of the wound of another tea tree oil group
pictures were taken on enrollment (A), 2 weeks after tea tree oi
dressing intervention (C).the reason why Hong Kong Public Hospitals have adopted
MRSA infections as a key performance indicator for the
assessment of patient safety [22]. In addition, pharmaceutical
investment in antimicrobial agents has declined in the past
decade, leading to a decreasing number of new antimicrobial
drugs approved for marketing. In this regard, the necessity of
seeking a non-antibiotic strategy for MRSA wound treatment
becomes paramount. Furthermore, limited treatment options
are hampering MRSA containment. Wound chronicity
lengthens the period of infectivity, leading to spread of
infection and adding challenges to infection control, which is
another key concern. In effect, both concerns translate to
increasing the direct and indirect healthcare cost and high
morbidity and mortality in our healthcare system.
Delayed wound healing in chronic wounds due to MRSA
colonization has contributed to adverse patient outcomes. In
nursing homes, it may not be limited to having a profound
effect on residents’ sense of well-being, comfort and quality
of life, but also contributes to more demand for resources for
wound management practice and rising costs to our
healthcare system for treatment for complications associ-
ated with non-healing wounds [23]. In addition, many long-
term care facilities in western countries refuse to admit
elderly people with MRSA-colonized wounds due to the
manpower needed to apply restrictive isolation precautions,
and this may compromise their ability to access appropriate
healthcare.participant who had a foot ulcer of 3 months duration. The
l dressing intervention (B) and 4 weeks after treatment
Table 6eOne-wayANOVA comparing the control and tea
tree oil groups in terms of PUSH scores.
PUSH score df F p
Baseline
Between groups 1 0.59 0.810
Within groups 30
Total 31
1st week
Between groups 1 9.37 <0.005
Within groups 30
Total 31
2nd week
Between groups 1 40.81 0.000
Within groups 30
Total 31
3rd week
Between groups 1 80.67 0.000
Within groups 30
Total 31
4th week
Between groups 1 71.60 0.000
Within groups 30
Total 31
i n t e r n a t i o n a l j o u rn a l o f n u r s i n g s c i e n c e s 1 ( 2 0 1 4 ) 7e1 4 13The evidence provided in the present study of tea tree oil’s
antibacterial and anti-inflammatory properties for MRSA
eradication and wound healing enhancement confirms its
value as a topical treatment in the context of MRSA contain-
ment and chronic wound management. In addition, tea tree
oil is a natural product, so the threat of antimicrobial resis-
tance can be avoided by reducing antibiotic use. As a result,
lower healthcare costs and improved quality of life for nursing
home residents can be achieved.5. Conclusion
The 10% topical tea tree preparation formulated by the
research team was successful in eradicating MRSA from
colonized wounds, and was able to promote and achieve re-
covery in chronic wounds that had shown a delay in healing.
Promoting wound healing and eradicating MRSA from wound
surfaces are two crucialmanagement strategies to prevent the
acquisition, carriage and dissemination of MRSA among res-
idents living in nursing homes and long-term care facilities.
The benefits are not limited to these institutions, but could
also extend to acute care settings and communities. Although
there have been many in-vitro studies on tea tree oil and
S. aureus, there are only a few published human studies in the
scientific literature, particular on older people. Little is known
about the pharmacology of tea tree oil in the human body,
thus conducting more research in this area to further
demonstrate the efficacy and patient tolerance of tea tree oil
as a topical treatment is of paramount importance.r e f e r e n c e s
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